Results 171 to 180 of about 59,693 (345)

Efficacy of low dose spironolactone in chronic kidney disease with resistant hypertension

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2011
To determine the antihypertensive benefit of adding low dose sprinolactone to multi-drug regimens that included a diuretic, a calcium channel blocker and angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with moderately ...
Rozita Abolghasmi, Omolbanin Taziki
doaj  

Nanomaterial‐Integrated 3D Biofabricated Structures for Advanced Biomedical Applications

open access: yesMacromolecular Materials and Engineering, EarlyView.
This review investigates the integration of nanomaterials into 3D biofabricated structures, highlighting the potential in tissue regeneration, wound healing, and cancer therapy. It discusses key techniques, including bioprinting and electrospinning, while addressing challenges such as biocompatibility, scalability, and regulatory barriers.
Mustafijur Rahman   +9 more
wiley   +1 more source

Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study. [PDF]

open access: bronze, 1980
Bengt Scherstén   +7 more
openalex   +1 more source

Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma is a poor prognosis cancer of the sympathetic nervous system that accounts for a disproportionate number of childhood cancer deaths. Many viable biological targets have been identified, and the number of potential combinations is even larger.
Steven G. DuBois   +44 more
wiley   +1 more source

Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects. [PDF]

open access: green, 1984
Millar Ja   +5 more
openalex   +1 more source

Muscle strength changes and physical activity during gender‐affirming hormone therapy: A systematic review

open access: yesAndrology, EarlyView.
Abstract Background Higher muscle strength is associated with improved overall health and lower mortality. Muscle strength changes during gender‐affirming hormone therapy is possibly linked to gender‐affirming hormone therapy modality, age at initiation, gender‐affirming hormone therapy duration, and physical activity.
Mathilde Kamp Nørlund   +7 more
wiley   +1 more source

Influence of outdoor time on the spherical equivalent and axial length in childhood myopia: A meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract This meta‐analysis investigates the effectiveness of outdoor activities in reducing the onset of myopia in children and adolescents by analysing changes in axial elongation and spherical equivalent refractive error. Following PRISMA guidelines and registered in PROSPERO (CRD42024592971), the study included randomized controlled trials (RCTs ...
Clara Martinez‐Perez   +4 more
wiley   +1 more source

Endocrine Abnormalities and Growth Pattern in Single Large‐Scale Mitochondrial DNA Deletion Syndromes

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To assess the prevalence of endocrine disorders and investigate growth patterns in single large‐scale mitochondrial DNA deletion syndromes (SLSMDs). Methods A retrospective study of all children with SLSMD who attended Sheba Medical Center, Israel, from February 2017 to September 2024.
Ayman Daka   +7 more
wiley   +1 more source

Systematic review of PSA reference intervals in the gender diverse population with prostates

open access: yesBJU International, EarlyView.
Objectives To determine mean/median serum total prostate‐specific antigen (PSA) levels in transgender women and non‐binary people with prostates (TWNBPP) who have received gender‐affirming hormone therapy (GAHT) or an orchidectomy. The secondary objective was to identify other quantitative information that influences PSA levels in this population ...
Rose Hall   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy